Abstract
No funding supported the writing of this commentary. The author has nothing to disclose.
MeSH terms
-
Administration, Intranasal
-
Aerosols
-
Affect / drug effects*
-
Antidepressive Agents / administration & dosage*
-
Antidepressive Agents / adverse effects
-
Antidepressive Agents / economics*
-
Cost-Benefit Analysis
-
Depressive Disorder, Treatment-Resistant / diagnosis
-
Depressive Disorder, Treatment-Resistant / drug therapy*
-
Depressive Disorder, Treatment-Resistant / economics*
-
Depressive Disorder, Treatment-Resistant / psychology
-
Drug Costs*
-
Evidence-Based Medicine
-
Humans
-
Ketamine / administration & dosage*
-
Ketamine / adverse effects
-
Ketamine / economics*
-
Patient Safety
-
Randomized Controlled Trials as Topic
-
Treatment Outcome
Substances
-
Aerosols
-
Antidepressive Agents
-
Esketamine
-
Ketamine